Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

AAO, ASCRS to Create Business Forums Held at Annual Meetings

The American Academy of Ophthalmology (AAO) and American Society of Cataract and Refractive Surgery (ASCRS) are adding a business forum to their annual meetings to bring together industry officials...

BreakingClinical TrialOphthalmicRetina
Korean Drugmaker Set for Phase I Study of Aflibercept Biosimilar Candidate

Alteogen expects to start a Phase I trial of ALT-L9, an aflibercept biosimilar candidate referencing Eylea, this month (October 2019), the South Korean drugmaker has indicated on

J&J Vision Surgical Reports Q3-2019 Revenue of $299 Million

The surgical unit of Johnson & Johnson Vision (J&J Vision) posted Q3-2019 revenue of $299 million, an increase of 0.9 percent over Q3-2018, parent Johnson & Johnson reported Oct. 15. Regional resul...

Kedalion Co-founder Mark Blumenkranz, MD, Named CEO

Kedalion Therapeutics of Menlo Park, California, announced Oct. 9 that Mark Blumenkranz, MD, will step into the role of CEO, while continuing as chairman. Current CEO Peter Noymer, PhD, is leaving ...

Myra Medical Raises $3.16 Million in Seed Money to Develop Glaucoma Device

Myra Medical announced Oct. 10 that it raised $3.16 million in its seed round of financing. The newly formed Shifamed portfolio company said the funding will be used to develop an improved device t...

Orasis’ Presbyopia Eye Drop Candidate Meets Endpoint in Phase IIb Trial

Orasis Pharmaceuticals announced Oct. 10 that CSF-1 met its primary endpoint in a Phase IIb trial for presbyopia. The Israel-based company is developing CSF-1 as an eye drop alternative to reading ...

Roche’s Q3-2019 Lucentis Sales Increase 7 Percent

Roche’s Lucentis sales in the US in Q3-2019 totaled $444.25 million (CHF 442 million), a 7 percent increase over Q3-2018, the Swiss company reported Oct. 16. Lucentis sales in the US for the first ...

BreakingDry EyeOphthalmicPharma
Sun Pharma Launches Cequa in the US for Dry Eye Disease

Sun Pharma has launched Cequa in the US, the India-based drugmaker announced Oct. 14. The twice-daily eye drop is indicated to increase tear production in patients with dry eye disease. Cequa is a ...

Join Market Scope Today

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

US Surveys
May select more than one
Outside of US Surveys

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2019 Market Scope, LLC. All Rights reserved.